Hepatitis C and B-cell lymphoma

Annals of Oncology

Volumn 14, Issue 9, 2003, Pages 1341-1345

  Turner, N C ^a   Dusheiko, G ^a   Jones, Alison ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Hepatitis C; Lymphoma; Pathogenesis

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN; STEROID;

B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER GRADING; CANCER REGRESSION; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTOPENIA; MALIGNANT TRANSFORMATION; PATHOGENESIS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; VIRUS REACTIVATION;

HEPATITIS C; HUMANS; LYMPHOMA, B-CELL;

EID: 0141836863     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg363     Document Type: Review

References (56)

1. Zuckerman E, Zuckerman T, Douer D et al. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-1230.
2. Vento S, Cainelli F, Mirandola F et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 92-93.
3. Monteverde A, Rivano MT, Allegra GC et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988; 79: 20-25.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
5. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577.
6. Pozzato G, Mazzaro C, Crovatto M et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053.
7. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20: 1442-1449.
8. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-1111.
9. Ferri C, Caracciolo F, Zignego AL. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394.
10. Silvestri F, Barillari G, Fanin R et al. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. Ann Oncol 1998; 9: 499-504.
11. Chindamo MC, Spector N, Segadas JA et al. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas. Oncol Rep 2002; 9: 657-659.
12. Mazzaro C, Zagonel V, Monfardini S et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550.
13. Montella M, Crispo A, Frigeri F et al. HCV and tumors correlated with immune system: a case-control study in an area of Hyperendemicity. Leuk Res 2001; 25: 775-781.
14. De Rosa G, Gobbo ML, De Renzo A et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82.
15. Vallisa D, Berte R, Rocca A et al. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106: 556-560.
16. Shirin H, Davidovitz Y, Avni Y et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J 2002; 4: 24-27.
17. Kuniyoshi M, Nakamuta M, Sakai H et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 215-219.
18. Mizorogi F, Hiramoto J, Nozato A et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-117.
19. Cucuianu A, Patiu M, Duma Mobile et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999; 107: 353-356.
20. Paydas S, Kilic B, Sahin B, Bugdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 1999; 80: 1303-1305.
21. Zucca E, Roggero E, Maggi-Solca N et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147-153.
22. Zuckerman E, Zuckerman T, Levine AM et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
23. Pioltelli P, Gargantini L, Cassi E et al. Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Haematol 2000; 64: 95-100.
24. De Vita S et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782.
25. Satoh T, Yamada T, Nakano S et al. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection. Cancer 1997; 80: 1981-1988.
26. De Vita S, Sansonno D, Dolcetti R. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887-1892.
27. Hausfater P, Cacoub P, Rosenthal E et al. Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group. Am J Hematol 2000; 64: 107-111.
28. Hausfater P, Cacoub P, Sterkers Y et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168-171.
29. McColl MD, Singer IO, Tait RC et al. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma - a regional association? Leuk Lymphoma 1997; 26: 127-130.
30. Collier JD, Zanke B, Moore Mobile et al. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 1259-1261.
31. Shariff S, Yoshida EM, Gascoyne RD et al. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol 1999; 10: 961-964.
32. Ellenrieder V, Weidenbach H, Frickhofen N et al. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34-39.
33. Kaya H, Polat MF, Erdem F, Gundogdu M. Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma. Clin Lab Haematol 2002; 24: 107-110.
34. Udomsakdi-Auewarakul C, Auewarakul P, Sukpanichnant S, Muangsup W. Hepatitis C virus infection in patients with non-Hodgkin lymphoma in Thailand. Blood 2000; 95: 3640-3641.
35. Rabkin CS, Tess BH, Christianson RE et al.Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-4242.
36. Ohsawa M, Shingu N, Miwa H et al. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 237-239.
37. Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002; 122: 568-571.
38. Conry-Cantilena C, VanRaden M, Gibble J et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
39. Farci P, Shimoda A, Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288: 339-344.
40. Morica G, Tambussi G, Sitia G et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 1999; 94: 1138-1139.
41. Murakami J, Shimizu Y, Kashii Y et al. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 1999; 30: 143-150.
42. Zuckerman E, Zuckerman T, Sahar D et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001; 112: 364-369.
43. Zuckerman E, Zuckerman T, Sahar D et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 1555-1559.
44. Karavattathayyil SJ, Kalkeri G, Liu HJ et al. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Am J Clin Pathol 2000; 113: 391-398.
45. Hussell T, Isaacson PG, Crabtree JE et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-574.
46. Quinn ER, Chan CH, Hadlock KG et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745-3749.
47. De Re V, De Vita S, Marzotto A et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578-3584.
48. Ivanovski M, Silvestri F, Pozzato G et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51 p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433-2442.
49. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 314-317.
50. Mazzaro C, Franzin F, Tulissi P et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996; 77: 2604-2613.
51. Patriarca F, Silvestri F, Fanin R et al. Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with α-interferon treatment. Br J Haematol 2001; 112: 370-372.
52. Hermine O, Lefrere F, Bronowicki J-P et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
53. Lok AS, Liang RH, Chiu EK et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182-188.
54. Markovic S, Drozina G, Vovk Mobile et al. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology 1999; 46: 2925-2930.
55. Frickhofen N, Wiesneth M, Jainta C et al. Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 1994; 83: 1998-2004.
56. Strasser SI, Sullivan KM, Myerson D et al. Cirrhosis of the liver in longterm marrow transplant survivors. Blood 1999; 93: 3259-3266.